NO893909L - Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.Info
- Publication number
- NO893909L NO893909L NO89893909A NO893909A NO893909L NO 893909 L NO893909 L NO 893909L NO 89893909 A NO89893909 A NO 89893909A NO 893909 A NO893909 A NO 893909A NO 893909 L NO893909 L NO 893909L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- imidazole derivatives
- therapeutic active
- active imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888823192A GB8823192D0 (en) | 1988-10-03 | 1988-10-03 | Chemical compounds |
| GB888823191A GB8823191D0 (en) | 1988-10-03 | 1988-10-03 | Chemical compounds |
| GB898902847A GB8902847D0 (en) | 1989-02-09 | 1989-02-09 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO893909D0 NO893909D0 (no) | 1989-10-02 |
| NO893909L true NO893909L (no) | 1990-04-04 |
Family
ID=27264106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89893909A NO893909L (no) | 1988-10-03 | 1989-10-02 | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5013749A (sv) |
| JP (1) | JPH02188571A (sv) |
| KR (1) | KR900006297A (sv) |
| AU (1) | AU628862B2 (sv) |
| BE (1) | BE1003007A3 (sv) |
| CH (1) | CH680442A5 (sv) |
| DE (1) | DE3932887A1 (sv) |
| DK (1) | DK483689A (sv) |
| ES (1) | ES2019163A6 (sv) |
| FI (1) | FI894648A (sv) |
| FR (1) | FR2637183A1 (sv) |
| GB (1) | GB2223224B (sv) |
| GR (1) | GR890100634A (sv) |
| IT (1) | IT1237470B (sv) |
| LU (1) | LU87600A1 (sv) |
| NL (1) | NL8902441A (sv) |
| NO (1) | NO893909L (sv) |
| PT (1) | PT91878B (sv) |
| SE (1) | SE8903226L (sv) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3913725A1 (de) * | 1989-04-26 | 1990-10-31 | Basf Ag | 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren |
| US5112819A (en) * | 1989-10-10 | 1992-05-12 | Glaxo Group Limited | Imidazole derivatives, pharmaceutical compositions and use |
| JPWO2002030425A1 (ja) * | 2000-10-12 | 2004-02-19 | 日産化学工業株式会社 | 糖尿病合併症予防・治療剤 |
| EP1389107A4 (en) * | 2001-04-27 | 2005-10-12 | Bristol Myers Squibb Co | BISARYLIMIDAZOLYL-FATTY ACID AMIDE-HYDROLASE INHIBITORS |
| KR20060133013A (ko) * | 2004-04-16 | 2006-12-22 | 워너-램버트 캄파니 엘엘씨 | 신규 이미다졸 |
| US20050272770A1 (en) * | 2004-04-29 | 2005-12-08 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US7199126B2 (en) | 2004-04-29 | 2007-04-03 | Pharmix Corporation | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US20060084695A1 (en) * | 2004-04-29 | 2006-04-20 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US7163945B2 (en) * | 2004-04-29 | 2007-01-16 | Pharmix Corp. | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US20050282883A1 (en) * | 2004-04-29 | 2005-12-22 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US7183285B2 (en) * | 2004-04-29 | 2007-02-27 | Pharmix Corp. | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| WO2006028524A2 (en) * | 2004-04-29 | 2006-03-16 | Pharmix Corporation | Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| US20060111436A1 (en) * | 2004-11-23 | 2006-05-25 | John Griffin | Compositions and treatments for modulating kinase and/or HMG-CoA reductase |
| US8372877B2 (en) | 2010-04-16 | 2013-02-12 | Cumberland Pharmaceuticals | Stabilized statin formulations |
| CN103153299A (zh) | 2010-10-06 | 2013-06-12 | 国立大学法人东京大学 | 淋巴水肿预防治疗剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| KR900001212B1 (ko) * | 1985-10-25 | 1990-02-28 | 산도즈 파마슈티칼스 코오포레이숀 | 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도 |
| EP0244364A3 (en) * | 1986-04-30 | 1992-04-01 | Sandoz Ag | Preparation of olefinic compounds |
| DE3800785A1 (de) * | 1988-01-09 | 1989-07-20 | Hoechst Ag | Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| NO890522L (no) * | 1988-02-25 | 1989-08-28 | Bayer Ag | Substituerte imidazolinoner og imidazolinthioner. |
-
1989
- 1989-10-02 AU AU42431/89A patent/AU628862B2/en not_active Ceased
- 1989-10-02 BE BE8901048A patent/BE1003007A3/fr not_active IP Right Cessation
- 1989-10-02 JP JP1257612A patent/JPH02188571A/ja active Pending
- 1989-10-02 US US07/415,917 patent/US5013749A/en not_active Expired - Fee Related
- 1989-10-02 DK DK483689A patent/DK483689A/da not_active Application Discontinuation
- 1989-10-02 IT IT04842489A patent/IT1237470B/it active IP Right Grant
- 1989-10-02 NO NO89893909A patent/NO893909L/no unknown
- 1989-10-02 NL NL8902441A patent/NL8902441A/nl not_active Application Discontinuation
- 1989-10-02 FR FR8912856A patent/FR2637183A1/fr active Pending
- 1989-10-02 DE DE3932887A patent/DE3932887A1/de not_active Withdrawn
- 1989-10-02 SE SE8903226A patent/SE8903226L/sv not_active Application Discontinuation
- 1989-10-02 PT PT91878A patent/PT91878B/pt not_active IP Right Cessation
- 1989-10-02 ES ES8903313A patent/ES2019163A6/es not_active Expired - Fee Related
- 1989-10-02 CH CH3584/89A patent/CH680442A5/de not_active IP Right Cessation
- 1989-10-02 LU LU87600A patent/LU87600A1/fr unknown
- 1989-10-02 FI FI894648A patent/FI894648A/fi not_active IP Right Cessation
- 1989-10-03 GR GR890100634A patent/GR890100634A/el unknown
- 1989-10-03 GB GB8922212A patent/GB2223224B/en not_active Expired - Fee Related
- 1989-10-04 KR KR1019890014335A patent/KR900006297A/ko not_active Application Discontinuation
-
1991
- 1991-01-09 US US07/639,184 patent/US5120848A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02188571A (ja) | 1990-07-24 |
| AU4243189A (en) | 1990-04-05 |
| GR890100634A (el) | 1990-11-29 |
| FI894648A0 (fi) | 1989-10-02 |
| DE3932887A1 (de) | 1990-04-05 |
| NL8902441A (nl) | 1990-05-01 |
| US5120848A (en) | 1992-06-09 |
| GB2223224B (en) | 1992-01-08 |
| NO893909D0 (no) | 1989-10-02 |
| KR900006297A (ko) | 1990-05-07 |
| SE8903226L (sv) | 1990-04-04 |
| GB2223224A (en) | 1990-04-04 |
| DK483689A (da) | 1990-04-04 |
| SE8903226D0 (sv) | 1989-10-02 |
| AU628862B2 (en) | 1992-09-24 |
| LU87600A1 (fr) | 1990-05-15 |
| BE1003007A3 (fr) | 1991-10-22 |
| PT91878A (pt) | 1990-04-30 |
| FI894648A (fi) | 1990-04-04 |
| ES2019163A6 (es) | 1991-06-01 |
| FR2637183A1 (fr) | 1990-04-06 |
| DK483689D0 (da) | 1989-10-02 |
| GB8922212D0 (en) | 1989-11-15 |
| PT91878B (pt) | 1995-05-31 |
| US5013749A (en) | 1991-05-07 |
| CH680442A5 (sv) | 1992-08-31 |
| IT1237470B (it) | 1993-06-07 |
| IT8948424A0 (it) | 1989-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO895086L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO891293D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol - og triazol-derivater. | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO884176L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
| NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO167739C (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater. | |
| NO891046D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. | |
| NO890607L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
| NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. |